Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haemonetics (HAE) Non-Current Deferred Tax Liability (2016 - 2025)

Haemonetics has reported Non-Current Deferred Tax Liability over the past 16 years, most recently at $56.0 million for Q4 2025.

  • For Q4 2025, Non-Current Deferred Tax Liability fell 8.9% year-over-year to $56.0 million; the TTM value through Dec 2025 reached $56.0 million, down 8.9%, while the annual FY2025 figure was $62.6 million, 58.26% down from the prior year.
  • Non-Current Deferred Tax Liability for Q4 2025 was $56.0 million at Haemonetics, down from $58.2 million in the prior quarter.
  • Over five years, Non-Current Deferred Tax Liability peaked at $149.9 million in Q1 2024 and troughed at $24.3 million in Q3 2021.
  • A 5-year average of $61.1 million and a median of $58.8 million in 2025 define the central range for Non-Current Deferred Tax Liability.
  • Biggest five-year swings in Non-Current Deferred Tax Liability: skyrocketed 1044.69% in 2021 and later tumbled 58.26% in 2025.
  • Year by year, Non-Current Deferred Tax Liability stood at $24.6 million in 2021, then skyrocketed by 63.39% to $40.2 million in 2022, then soared by 55.03% to $62.2 million in 2023, then fell by 1.28% to $61.5 million in 2024, then fell by 8.9% to $56.0 million in 2025.
  • Business Quant data shows Non-Current Deferred Tax Liability for HAE at $56.0 million in Q4 2025, $58.2 million in Q3 2025, and $59.5 million in Q2 2025.